Ipilimumab/pembrolizumabHypophysitis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1909卷 / 1期

关键词：

D O I：

10.1007/s40278-022-16593-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：306 / 306

相关论文

共 50 条

[31] Ipilimumab/nivolumabColitis: case report
Reactions Weekly, 2023, 1942 (1) : 157 - 157
[32] Ipilimumab/nivolumabHypophysitis: case report
Reactions Weekly, 2019, 1747 (1) : 159 - 159
[33] Ipilimumab/nivolumabNeurosarcoidosis: case report
Reactions Weekly, 2018, 1716 (1) : 170 - 170
[34] Ipilimumab/nivolumabPancreatitis: case report
Reactions Weekly, 2022, 1924 (1) : 259 - 259
[35] Ipilimumab/nivolumabColitis: case report
Reactions Weekly, 2020, 1826 (1) : 185 - 185
[36] Ipilimumab/nivolumabPneumonitis: case report
Reactions Weekly, 2023, 1967 (1) : 207 - 207
[37] Ipilimumab/nivolumabTransaminitis: case report
Reactions Weekly, 2018, 1729 (1) : 152 - 152
[38] Ipilimumab/nivolumabAcrocyanosis: case report
Reactions Weekly, 2020, 1833 (1) : 215 - 215
[39] Ipilimumab/NivolumabHepatotoxicity: case report
Reactions Weekly, 2024, 2038 (1) : 168 - 168
[40] Ipilimumab/NivolumabMyocarditis: case report
Reactions Weekly, 2025, 2050 (1) : 284 - 284

← 1 2 3 4 5 →